Staph Solutions
Staph Solutions
AR
United States
ph: 501.261.7812
fax: 501.315.1890
alt: 877.275.6853
david
MANUFACTURER
Howard Phillips, Founder
Phoenix-Mesa, AZ (1888PressRelease) October 26, 2007 - MRSA, a form of Staph infection, recently became the contributor to more deaths than AIDS. Antibiotics are not effective when used to treat many bacterial infections, including MRSA, which has contributed to an estimated 18,000 deaths nationally every year, as widely reported earlier this month.
Acting on a new business model, Phillips Company announced on October 26 that it has become the world's first not-for-profit company to manufacture new anti-MRSA products that kill MRSA bacteria without the use of antibiotics.Phillips Company is the world’s first non-profit manufacturing company whose aim is to "identify low-cost health solutions that are not being developed, match these solutions with very important skin diseases and take these solutions to the people who need them." Many simple low-cost and effective health-care solutions are not available because pharmaceutical companies have no incentive to put them through clinical trials necessary to get regulatory approval. Sometimes this is because the low-cost solution can not be patented or because it costs millions of dollars for clinical trials needed to get regulatory approval.
Phillips Company was inspired by the formation of a San Francisco-based nonprofit, Institute for OneWorld Health; an organization that is partnering with foundations, for-profit drug companies, NGOs, and governments around the world to bring neglected drugs to market. Both companies were formed as nonprofits because the pharmaceutical industry spends billions of dollars developing medical drugs to cure the ailments of wealthy Westerners, but very little to treat the diseases that kill millions of people every year in the US and in the developing world.
Staph Solutions
AR
United States
ph: 501.261.7812
fax: 501.315.1890
alt: 877.275.6853
david
